News & Recognition

Lori Orlando, MD, MHS, MMCI, director of the precision medicine program in the Center for Applied Genomics & Precision Medicine at Duke University School of Medicine, spoke at the Washington State University Elson S. Floyd College of Medicine 2021 Genomics & Adoption Symposium today.

Geoffrey Ginsburg, MD, PhD, a professor of Medicine (Cardiology), Pathology, Biostatistics and Bioinformatics, and Biomedical Engineering, and a professor in School of Nursing, will leave Duke to assume the role of Chief Medical and Scientific Officer for the National Institutes of Health (NIH) All of Us Research Program, effective January 2022. In this role, Dr. Ginsburg will help direct the national scientific research agenda to improve health and accelerate research using precision medicine.

CAGPM and the Duke Center for Genomic and Computational Biology (GCB) have partnered with North Carolina Central University (NCCU) for the Summer Scholars Program in Genome Sciences and Medicine, supported by an R25 grant by the National Human Genome Research Institute at NIH.

A new study by Duke researchers, including Duke Center for Applied Genomics members Deepak Voora, MD, Geoffrey Ginsburg, MD, PhD, and first author, Rachel Meyers, PhD, explores why aspirin may not work as well as expected against stroke and heart attack and to better understand any differences between low- and high-dose aspirin – one of the most commonly used medications worldwide.

Ricardo Henao, PhD, Duke Center for Applied Genomics & Precision Medicine faculty and assistant professor in Biostatistics & Bioinformatics, collaborating with co-investigators, recently published “Evaluation of an RNAseq-Based Immunogenomic Liquid Biopsy Approach in Early-Stage Prostate Cancer” in Cells.

On the heels of October highlighting breast cancer awareness and entering November when National Family Health History month is recognized, Dr. Ryanne Wu, MD, MHS, Associate Professor of Medicine and faculty at the Duke Center for Applied Genomics & Precision Medicine (CAGPM), recently completed a study on the “Development and Clinical Implementation Pilot of an Oncology-specific Risk Assessment tool in Singapore”, funded by the Duke/Duke-National University of Singapore (NUS) Research Collaboration funding mechanism.

Duke Center for Applied Genomics & Precision Medicine faculty member, Ephraim Tsalik, MD, PhD, has received a grant from the Department of Defense to pursue, “Rapid, point-of-care, host gene expression test for presymptomatic viral infection and to distinguish bacterial from viral illness.”

Jennifer Doudna, PhD, professor of chemistry, biochemistry, and molecular biology at the University of California, Berkeley, is a leading figure in the CRISPR revolution.

Director of the Precision Medicine Program in CAGPM, Lori Orlando, MD, MHS, MMCI, has received an R01 grant to pursue, "Deploying a genomic-medicine risk assessment model for diverse primary care populations and settings."

Meet Brittany Vekstein, the new Communications Specialist for The Center for Applied Genomics and Precision Medicine!